Preci-Health Announces Strategic Investment and U.S. Clinical Partnership with Intermountain Health
August 18th 2025 | Neuchâtel, Switzerland
Preci-Health, developer of a breakthrough needle-free blood collection device, is proud to announce a strategic investment and clinical collaboration with Intermountain Health, a nonprofit healthcare system based in Utah, USA.
Intermountain Health, which operates 385 clinics and 33 hospitals across the Intermountain West, joins Preci-Health not only as an investor but as a key U.S. supporter as Preci-Health seeks clinical validation.
“We are honored to welcome Intermountain Health as both an investor and collaborator,” said Paul Kirschgraber MD, MBA, Chairman of the Board at Preci-Health: “Their deep clinical expertise, commitment to innovation, and strong reputation within the U.S. healthcare systems make them the ideal ally as we prepare to launch in 2026.”
The collaboration will accelerate the development and validation of ezdrawTM, a user-friendly device enabling blood sample collection without needles. It’s designed for use in hospitals, clinics, labs, pharmacies, and even at home. The device aims to simplify the way patients experience blood collection with two tubes in one draw, solving key challenges in phlebotomy — from patient discomfort to improving caregiver workload.
Intermountain Health will support Preci-Health through the FDA approval process including Institutional Review Board approved studies. These studies will include participants in northern and central Utah. Intermountain will also support Preci-Health to evaluate the integration of ezdrawTM in various capacities including, but not limited to clinic-based preventive health, and home-based remote diagnostics and chronic disease monitoring.
“We’re excited to support this transformative technology that has the potential to significantly impact global healthcare, by improving access, providing a better patient experience, and streamlining care delivery,” said Karen Brownell, VP, Laboratory Services, Intermountain Health.
This investment follows prior validations and collaborations with global leaders in space, a top-10 pharmaceutical company, and two of Europe’s leading diagnostic laboratories.
About PreciHealth SA
Preci-Health, a Swiss-based medtech and AI innovator, is redefining the 80 billion in vitro diagnostics (IVD) industry with ezdrawTM —an advanced blood sampling solution that eliminates the need for trained phlebotomists. Designed for both at-clinic and at-home use, ezdrawTM offers unparalleled convenience and precision, making it a game-changer in remote healthcare.
About Intermountain Health
Headquartered in Utah with locations in six states and additional operations across the western U.S., Intermountain Health is a not-for-profit system of 33 hospitals, approximately 400 clinics, medical groups with some 4,600 employed physicians and advanced care providers, a health plans division called Select Health with more than one million members, and other health services. Helping people live the healthiest lives possible, Intermountain is committed to improving community health and is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes at sustainable costs.
Media Contact:
Laurence Blazianu, CBO, l.blazianu@precihealth.com
Holly Nelson, Media Relations Manager, Intermountain Health, holly.nelson2@imail.org